{
  "ProtocolSection": {
    "IdentificationModule": {
      "NCTId": "NCT03078621",
      "OrgStudyIdInfo": {
        "OrgStudyId": "SCA-CP1"
      },
      "Organization": {
        "OrgFullName": "Stem Cells Arabia",
        "OrgClass": "OTHER"
      },
      "BriefTitle": "Bone Marrow-Derived Stem Cell Transplantation for the Treatment of Cerebral Palsy",
      "OfficialTitle": "Safety and Efficacy of Transplantation of Specific Populations of Stem Cells and Mesenchymal Stem Cells for the Treatment of Cerebral Palsy"
    },
    "StatusModule": {
      "StatusVerifiedDate": "March 2020",
      "OverallStatus": "Active, not recruiting",
      "ExpandedAccessInfo": {
        "HasExpandedAccess": "No"
      },
      "StartDateStruct": {
        "StartDate": "September 2016"
      },
      "PrimaryCompletionDateStruct": {
        "PrimaryCompletionDate": "October 2020",
        "PrimaryCompletionDateType": "Anticipated"
      },
      "CompletionDateStruct": {
        "CompletionDate": "January 2021",
        "CompletionDateType": "Anticipated"
      },
      "StudyFirstSubmitDate": "February 25, 2017",
      "StudyFirstSubmitQCDate": "March 7, 2017",
      "StudyFirstPostDateStruct": {
        "StudyFirstPostDate": "March 13, 2017",
        "StudyFirstPostDateType": "Actual"
      },
      "LastUpdateSubmitDate": "March 15, 2020",
      "LastUpdatePostDateStruct": {
        "LastUpdatePostDate": "March 17, 2020",
        "LastUpdatePostDateType": "Actual"
      }
    },
    "SponsorCollaboratorsModule": {
      "ResponsibleParty": {
        "ResponsiblePartyType": "Sponsor"
      },
      "LeadSponsor": {
        "LeadSponsorName": "Stem Cells Arabia",
        "LeadSponsorClass": "OTHER"
      }
    },
    "OversightModule": {
      "OversightHasDMC": "No"
    },
    "DescriptionModule": {
      "BriefSummary": "This study is a single arm, single center trial to study the safety and efficacy of purified autologous bone marrow derived stem cells and mesenchymal stem cells for the treatment of children with cerebral palsy.",
      "DetailedDescription": "Cerebral palsy (CP) is a chronic childhood disorder defined by a range of motor and cognitive impairments and results in a substantial suffering to the patient and a tremendous socio-economic burden to the individual, family, and healthcare system. With no effective treatments or interventions, therapies for CP are currently focused on supportive and management strategies. Stem cell transplantation has been suggested as a putative intervention for neural pathology, as mesenchymal and neural stem cells, as well as olfactory ensheathing glia and Schwann cells, which have shown some regenerative and functional efficacy in experimental central nervous system disorders.\n\nIn this trial, the investigators study the safety and efficacy of the intrathecal transplantation of specific populations of purified autologous bone marrow-derived stem cells and mesenchymal stem cells in patients with cerebral palsy."
    },
    "ConditionsModule": {
      "ConditionList": {
        "Condition": [
          "Cerebral Palsy"
        ]
      },
      "KeywordList": {
        "Keyword": [
          "stem cells"
        ]
      }
    },
    "DesignModule": {
      "StudyType": "Interventional",
      "PhaseList": {
        "Phase": [
          "Phase 1",
          "Phase 2"
        ]
      },
      "DesignInfo": {
        "DesignAllocation": "N/A",
        "DesignInterventionModel": "Single Group Assignment",
        "DesignPrimaryPurpose": "Treatment",
        "DesignMaskingInfo": {
          "DesignMasking": "None (Open Label)"
        }
      },
      "EnrollmentInfo": {
        "EnrollmentCount": "50",
        "EnrollmentType": "Anticipated"
      }
    },
    "ArmsInterventionsModule": {
      "ArmGroupList": {
        "ArmGroup": [
          {
            "ArmGroupLabel": "Stem Cells",
            "ArmGroupType": "Experimental",
            "ArmGroupDescription": "Intravenous and Intrathecal transplantation of specific populations of purified bone marrow-derived stem cells and mesenchymal stem cells.",
            "ArmGroupInterventionList": {
              "ArmGroupInterventionName": [
                "Biological: Stem Cell Therapy"
              ]
            }
          }
        ]
      },
      "InterventionList": {
        "Intervention": [
          {
            "InterventionType": "Biological",
            "InterventionName": "Stem Cell Therapy",
            "InterventionDescription": "Intravenous and Intrathecal transplantation of purified autologous bone marrow-derived stem cells and mesenchymal stem cells.",
            "InterventionArmGroupLabelList": {
              "InterventionArmGroupLabel": [
                "Stem Cells"
              ]
            }
          }
        ]
      }
    },
    "OutcomesModule": {
      "PrimaryOutcomeList": {
        "PrimaryOutcome": [
          {
            "PrimaryOutcomeMeasure": "Changes in Motor Performance.",
            "PrimaryOutcomeDescription": "GMPM (Gross Motor Performance Measure) as a standard measurement tool for assessing quality of movement.",
            "PrimaryOutcomeTimeFrame": "6 months"
          }
        ]
      },
      "SecondaryOutcomeList": {
        "SecondaryOutcome": [
          {
            "SecondaryOutcomeMeasure": "Motor function studies",
            "SecondaryOutcomeDescription": "Total volumes and specific tract lesions will be studied and correlated with functional outcomes.",
            "SecondaryOutcomeTimeFrame": "1 year"
          },
          {
            "SecondaryOutcomeMeasure": "Specific white matter tract analysis using MRI",
            "SecondaryOutcomeDescription": "Changes on brain Diffusion Tensor Image (DTI).",
            "SecondaryOutcomeTimeFrame": "6 months"
          }
        ]
      }
    },
    "EligibilityModule": {
      "EligibilityCriteria": "Inclusion Criteria:\n\nMust be more than 2 year of age and less than 12 years of age at the time of screening for inclusion in the study.\nClinical evidence of a non-progressive motor disability due to brain dysfunction.\nWilling to comply with all study procedures.\nGross Motor Function Classification Score level II-V\n\nExclusion Criteria:\n\nKnown history of:\n\nIntractable seizures\nTraumatic brain injury\nGenetic disorder\nCurrent Infection\nRenal insufficiency\nHepatic disease\nHIV+ (as demonstrated by positive blood test)\nImmunosuppression\nInfectious related neurological injury\nOther etiologies such as degenerative, mitochondrial, and metabolic disorders\nNormal brain MRI\nEvidence of acute illness such as fever (temperature > 37.5 C), vomiting, diarrhea, wheezing or crackles\nProgressing neurological disease (Batten Disease, Leukodystrophies, Neurotransmitter disorders)\nMicrocephaly, macrocephaly, cortical malformations, or genetic disorders of dysgenesis\nPulmonary disease requiring ventilator support\nUnwillingness to return for follow-up visits\nContraindications to MRI",
      "HealthyVolunteers": "No",
      "Gender": "All",
      "MinimumAge": "2 Years",
      "MaximumAge": "12 Years",
      "StdAgeList": {
        "StdAge": [
          "Child"
        ]
      }
    },
    "IPDSharingStatementModule": {
      "IPDSharing": "Undecided"
    }
  },
  "DerivedSection": {
    "MiscInfoModule": {
      "VersionHolder": "January 20, 2022"
    },
    "ConditionBrowseModule": {
      "ConditionMeshList": {
        "ConditionMesh": [
          {
            "ConditionMeshId": "D000002547",
            "ConditionMeshTerm": "Cerebral Palsy"
          }
        ]
      },
      "ConditionAncestorList": {
        "ConditionAncestor": [
          {
            "ConditionAncestorId": "D000009422",
            "ConditionAncestorTerm": "Nervous System Diseases"
          },
          {
            "ConditionAncestorId": "D000001925",
            "ConditionAncestorTerm": "Brain Damage, Chronic"
          },
          {
            "ConditionAncestorId": "D000001927",
            "ConditionAncestorTerm": "Brain Diseases"
          },
          {
            "ConditionAncestorId": "D000002493",
            "ConditionAncestorTerm": "Central Nervous System Diseases"
          }
        ]
      },
      "ConditionBrowseLeafList": {
        "ConditionBrowseLeaf": [
          {
            "ConditionBrowseLeafId": "M12309",
            "ConditionBrowseLeafName": "Paralysis",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4948",
            "ConditionBrowseLeafName": "Cerebral Palsy",
            "ConditionBrowseLeafAsFound": "Cerebral Palsy",
            "ConditionBrowseLeafRelevance": "high"
          },
          {
            "ConditionBrowseLeafId": "M4359",
            "ConditionBrowseLeafName": "Brain Injuries",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4354",
            "ConditionBrowseLeafName": "Brain Damage, Chronic",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4356",
            "ConditionBrowseLeafName": "Brain Diseases",
            "ConditionBrowseLeafRelevance": "low"
          },
          {
            "ConditionBrowseLeafId": "M4894",
            "ConditionBrowseLeafName": "Central Nervous System Diseases",
            "ConditionBrowseLeafRelevance": "low"
          }
        ]
      },
      "ConditionBrowseBranchList": {
        "ConditionBrowseBranch": [
          {
            "ConditionBrowseBranchAbbrev": "BC10",
            "ConditionBrowseBranchName": "Nervous System Diseases"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC23",
            "ConditionBrowseBranchName": "Symptoms and General Pathology"
          },
          {
            "ConditionBrowseBranchAbbrev": "All",
            "ConditionBrowseBranchName": "All Conditions"
          },
          {
            "ConditionBrowseBranchAbbrev": "BC26",
            "ConditionBrowseBranchName": "Wounds and Injuries"
          }
        ]
      }
    }
  }
}